Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness

Abstract

Patients with PCP with no predisposing illnesses were older and had higher mortality rates than IC patients with PCP. Delayed anti-PCP treatment was associated with increased 90-day mortality.